TherapeuticsMD Inc expected to post a loss of 12  cents a share - Earnings Preview

TherapeuticsMD

04/05/2021 14:39

* TherapeuticsMD Inc  TXMD.OQ   TXMD.O  is expected to show
a rise in quarterly revenue when it reports results on May 6.
* The Boca Raton, Florida-based company is expected to report  a
61.4% increase in revenue to $19.768 million from $12.25 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data.​​
​* Refinitiv's mean analyst estimate for TherapeuticsMD Inc is
for a loss of 12 cents per share. For the same quarter last
year, the company reported a loss of 21 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months.​
* Wall Street's median 12-month price target for TherapeuticsMD
Inc is $5.5​, about 79.1% above​ its last closing price
of $1.15. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.11       -0.10      -0.15     Missed  -42.9
 Sep. 30 2020  -0.14       -0.14      -0.12     Beat    12.2
 Jun. 30 2020  -0.17       -0.17      -0.19     Missed  -10.7​
 Mar. 31 2020  -0.19       -0.19      -0.21     Missed  -12
 Dec.          -0.19​      -0.19      -0.19     Met     -1.5​
 31​ 2019​                                              
 Sep. 30 2019  -0.19       -0.19      -0.13     Beat    32.2​
 Jun. 30 2019  -0.17       -0.17      -0.19     Missed  -10.2
 Mar. 31 2019  -0.16       -0.17      -0.16     Beat    4
 This summary was machine generated May 4 at 13:39 GMT.  All
figures in US dollars unless otherwise stated